Agenus Inc (STU:AJ8)
€ 7.952 0 (0%) Market Cap: 159.15 Mil Enterprise Value: 160.92 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 46/100

Agenus Inc to Host “The Road Taken” R&D Event Transcript

Nov 12, 2022 / 07:00PM GMT
Garo H. Armen
Agenus Inc. - Founder, Executive Chairman & CEO

(technical difficulty)

what we're doing and how we're doing it. And so you'll hear from a number of speakers, and I'll go over some of them. There'll be 4 speakers who are experts in their field. Some have been experts for a long time. Some are new kids on the block, not that new, but young kids like Bree Wilky, who have become experts instantly.

Now they will include our good friends, Mike Atkins, who was the winner of the Lifetime Achievement Award. But Mike probably goes back in history in the journey of immuno-oncology for a very long time, the mid-80s before several years before, I woke up to my conviction that immunology would be the only way to cure cancer. That was in the very early '90s. And when I met Mike in the early 2000s, he told me something that was very memorable. He said, this is way before the approval. He said CTLA-4 works. It was, I think, in 2003 or 2004. So he is a man of conviction that has persisted in this journey for a long time.

Dr. Larry Norton, who I've known since the late '90s, I

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot